NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 44 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,855 | -53.5% | 46,970 | 0.0% | 0.05% | -58.1% |
| Q2 2023 | $87,834 | -49.5% | 46,970 | -95.0% | 0.12% | +6.9% |
| Q1 2023 | $173,791 | -2.7% | 939,412 | 0.0% | 0.12% | +18.4% |
| Q4 2022 | $178,676 | -51.8% | 939,412 | 0.0% | 0.10% | -52.7% |
| Q3 2022 | $371,000 | -62.4% | 939,412 | 0.0% | 0.21% | -58.3% |
| Q2 2022 | $986,000 | -44.2% | 939,412 | 0.0% | 0.50% | -32.9% |
| Q1 2022 | $1,766,000 | -33.1% | 939,412 | 0.0% | 0.74% | -30.0% |
| Q4 2021 | $2,640,000 | – | 939,412 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $494,000 | 0.50% |
| CARNEGIE MELLON UNIVERSITY | 939,412 | $986,000 | 0.50% |
| CM Management, LLC | 370,000 | $389,000 | 0.41% |
| Decheng Capital Management III (Cayman), LLC | 1,000,000 | $1,050,000 | 0.40% |
| Sio Capital Management, LLC | 906,445 | $952,000 | 0.36% |
| AIGH Capital Management LLC | 1,027,585 | $1,079,000 | 0.28% |
| Greenlight Capital | 2,727,027 | $2,863,000 | 0.22% |
| Worth Venture Partners, LLC | 256,553 | $249,000 | 0.15% |
| PERKINS CAPITAL MANAGEMENT INC | 81,500 | $86,000 | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $327,000 | 0.01% |